Hisato Hara

1.3k citations
60 papers · 875 indexed · h-index 17
Topics
Thyroid Cancer Diagnosis and Treatment (13 papers)Cancer, Hypoxia, and Metabolism (10 papers)Adrenal and Paraganglionic Tumors (7 papers)

In The Last Decade

Hisato Hara

55 papers receiving 858 citations

Peers

Hisato Hara
Comparison fields: 5 of 79
  • Oncology 349
  • Endocrinology, Diabetes and Metabolism 256
  • Molecular Biology 223
  • Cancer Research 198
  • Surgery 183
Replace Madhuchhanda Roy with:
Madhuchhanda Roy United States
Tamara Aleksic United Kingdom
Svetislav Tatić Serbia
Jin Hyung Heo South Korea
Ning Qu China
Marilyn M. Giacomini United States
Peter Gaßmann Germany
Hidemi Kawajiri Japan
Javier Molina‐Cerrillo Spain
Tetsushi Saishoji Japan
Hisato Hara relative to Madhuchhanda Roy United States Madhuchhanda Roy's profile →
Citations per field
00.5×2.6×
Madhuchhanda Roy · 1×
Citations per year

Countries citing papers authored by Hisato Hara

Since Specialization
Citations

This map shows the geographic impact of Hisato Hara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hisato Hara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hisato Hara more than expected).

Fields of papers citing papers by Hisato Hara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hisato Hara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hisato Hara. The network helps show where Hisato Hara may publish in the future.

Co-authorship network of co-authors of Hisato Hara

This figure shows the co-authorship network connecting the top 25 collaborators of Hisato Hara. A scholar is included among the top collaborators of Hisato Hara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hisato Hara. Hisato Hara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 5
2 9
3 4
4 8
5 5
6 32
7 17
8 5
9 2
10 8
11 8
12 0
13 41
14 7
15 4
16 12
17 28
18 5
19 24
20 2

About Hisato Hara

Hisato Hara is a scholar working on Cancer Research, Endocrinology, Diabetes and Metabolism and Oncology, having authored 60 papers that have together received 875 indexed citations. Recurring topics across this work include Thyroid Cancer Diagnosis and Treatment (13 papers), Cancer, Hypoxia, and Metabolism (10 papers) and Adrenal and Paraganglionic Tumors (7 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (256 citations), Nephrology (98 citations) and Cancer Research (198 citations). Hisato Hara has collaborated with scholars based in Japan, United States and Pakistan. Frequent co-authors include Tohru Yashiro, Hiroko Bando, Kazuhiro Takekoshi, Yasushi Kawakami, Kiyo‐aki Ishii, Takao Obara, Yukiko Yano, Ei Ueno, Hitoshi Shimano and Yuji Aiyoshi. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026